+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Effects of Y132H and F145L substitutions on the activity, azole resistance and spectral properties of Candida albicans sterol 14-demethylase P450 (CYP51): a live example showing the selection of altered P450 through interaction with environmental compounds



Effects of Y132H and F145L substitutions on the activity, azole resistance and spectral properties of Candida albicans sterol 14-demethylase P450 (CYP51): a live example showing the selection of altered P450 through interaction with environmental compounds



Journal of Biochemistry 137(5): 625-632



Three variants of Candida albicans CYP51 (sterol 14-demethylase P450) having Y132H and/or F145L substitutions were purified and characterized to reveal the effects of these amino acid substitutions on the enzymatic properties and azole resistance of the enzyme. Y132H and F145L substitutions modified the spectral properties of the enzyme, suggesting that they caused some structural change modifying the heme environments of CYP51. Y132H and F145L substitutions increased the resistance of the enzyme to azole compounds but considerably decreased the catalytic activity. This fact represents a trade-off between acquisition of azole resistance and maintenance of high activity in the CYP51 having Y132H and F145L substitutions. A fluconazole-resistant C. albicans strain DUMC136 isolated from patients receiving long-term azole treatment was a homozygote of the altered CYP51 having Y132H and F145L substitutions. However, neither of these substitutions was found in CYP51 of wild-type C. albicans so far studied. These facts suggest that the azole-resistant variant having Y132H and/or F145L substitutions might be selected only under azole-rich environments because of its azole resistance and impaired catalytic activity. This may be a live example showing one of the important processes of P450 diversification, the selection of altered P450 through the interaction with environmental compounds.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 013115821

Download citation: RISBibTeXText

PMID: 15944416

DOI: 10.1093/jb/mvi073


Related references

The Evolution of Azole Resistance in Candida albicans Sterol 14α-Demethylase (CYP51) through Incremental Amino Acid Substitutions. Antimicrobial Agents and ChemoTherapy 63(5):, 2019

Emergence of fluconazole-resistant sterol 14-demethylase P450 (CYP51) in Candida albicans is a model demonstrating the diversification mechanism of P450. Archives of Biochemistry and Biophysics 379(1): 170-171, 2000

Amino acid substitutions Y132H and I471T in the 14a-demethylase of Darlington strain of Candida albicans contribute to azole resistance. Abstracts of the General Meeting of the American Society for Microbiology 99: 308, 1999

Fungal cytochrome P450 sterol 14α-demethylase (CYP51) and azole resistance in plant and human pathogens. Applied Microbiology and Biotechnology 95(4): 825-840, 2012

Formation of azole-resistant Candida albicans by mutation of sterol 14-demethylase P450. Antimicrobial Agents and ChemoTherapy 43(5): 1163-1169, 1999

Formation of Azole-Resistant Candida albicans by Mutation of Sterol 14-Demethylase P450. Antimicrobial Agents and Chemotherapy 43(5): 1163-1169, 1999

The amino acid residues affecting the activity and azole susceptibility of rat CYP51 (sterol 14-demethylase P450). Journal of Biochemistry 129(5): 761-768, 2001

Three-dimensional modeling of cytochrome P450 14 alpha-demethylase (CYP51) and interaction of azole fungicide metconazole with CYP51. New Discoveries in Agrochemicals 892: 142-150, 2005

Azole affinity of sterol 14α-demethylase (CYP51) enzymes from Candida albicans and Homo sapiens. Antimicrobial Agents and ChemoTherapy 57(3): 1352-1360, 2013

Emergence of fluconazole-resistant sterol 14-demethylase P450 in Candida albicans is a model demonstrating the diversification mechanism of P450. Archives of Biochemistry & Biophysics 379(1): 170-171, 2000

Crystal structure of cytochrome P450 14a-sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors. Proceedings of the National Academy of Sciences of the United States of America 98(6): 68-73, 2001

Azole Affinity of Sterol 14alpha-Demethylase CYP51 Enzymes from Candida albicans and Homo sapiens. 2013

Contribution of mutations in the cytochrome P450 14a-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans. Microbiology 145 pt10: 01-13, 1999

Crystal structure of cytochrome P450 14alpha -sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors. Proceedings of the National Academy of Sciences of the United States of America 98(6): 3068-3073, 2001

Contribution of mutations in the cytochrome P450 14alpha-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans. Microbiology 145: 2701-2713, 1999